Compounding Issues Archives

  • Jun 5, 2017 4

    FDA Committee Sides With Big Pharma… Again

    FDA’s Pharmacy Compounding Advisory Committee has voted to limit your access to drugs not made by drug companies. Action Alert! A few weeks ago, we told you that the FDA’s Pharmacy Compounding Advisory Committee (PCAC) was meeting once again to decide whether patients will have access to custom...

  • Nov 13, 2014 1

    Problems with Compounding Regulation?

    Recent regulations released by the FDA contain several provisions that are harmful to doctors, patients, and compounding pharmacists. Office Use: This is an area of the rulemaking that has garnered the biggest reaction from the compounding community. Congress and the FDA have required a patient-spe...